Literature DB >> 18515321

Speech perception ability in individuals with Friedreich ataxia.

Gary Rance1, Rosanne Fava, Heath Baldock, April Chong, Elizabeth Barker, Louise Corben, Martin B Delatycki.   

Abstract

The aim of this study was to investigate auditory pathway function and speech perception ability in individuals with Friedreich ataxia (FRDA). Ten subjects confirmed by genetic testing as being homozygous for a GAA expansion in intron 1 of the FXN gene were included. While each of the subjects demonstrated normal, or near normal sound detection, 3 of the 10 showed electrophysiological evidence of auditory pathway disorder [presenting with the auditory neuropathy/dyssynchrony (AN/AD) result pattern], and 9 of the 10 showed abnormal speech understanding when tested with levels of background noise typical of everyday listening conditions. Information transmission analyses of the speech perception findings for the three FRDA subjects with AN/AD type hearing loss when compared with those of a cohort of individuals with peripheral [sensorineural (SN)] hearing loss, showed a distinct pattern of perceptual disruption. Where the listeners with SN loss confused sounds on the basis of frequency (pitch) differences, the FRDA subjects with AN/AD made errors that reflected an inability to perceive temporal (timing) cues in the speech sounds.

Entities:  

Mesh:

Year:  2008        PMID: 18515321     DOI: 10.1093/brain/awn104

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  38 in total

1.  A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.

Authors:  Marguerite V Evans-Galea; Louise A Corben; Justin Hasell; Charles A Galea; Michael C Fahey; Desirée du Sart; Martin B Delatycki
Journal:  Neurogenetics       Date:  2011-08-10       Impact factor: 2.660

Review 2.  Remote Microphone Technology for Children with Hearing Loss or Auditory Processing Issues.

Authors:  Erin C Schafer; Benjamin Kirby; Sharon Miller
Journal:  Semin Hear       Date:  2020-12-16

3.  Temporal Response Properties of the Auditory Nerve in Implanted Children with Auditory Neuropathy Spectrum Disorder and Implanted Children with Sensorineural Hearing Loss.

Authors:  Shuman He; Paul J Abbas; Danielle V Doyle; Tyler C McFayden; Stephen Mulherin
Journal:  Ear Hear       Date:  2016 Jul-Aug       Impact factor: 3.570

Review 4.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

5.  Cortical maturation and behavioral outcomes in children with auditory neuropathy spectrum disorder.

Authors:  Anu Sharma; Garrett Cardon; Kathryn Henion; Peter Roland
Journal:  Int J Audiol       Date:  2011-02       Impact factor: 2.117

6.  Auditory function in individuals within Leber's hereditary optic neuropathy pedigrees.

Authors:  Gary Rance; Lisa S Kearns; Johanna Tan; Anthony Gravina; Lisa Rosenfeld; Lauren Henley; Peter Carew; Kelley Graydon; Fleur O'Hare; David A Mackey
Journal:  J Neurol       Date:  2011-09-02       Impact factor: 4.849

7.  An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.

Authors:  Eppie M Yiu; Geneieve Tai; Roger E Peverill; Katherine J Lee; Kevin D Croft; Trevor A Mori; Barbara Scheiber-Mojdehkar; Brigitte Sturm; Monika Praschberger; Adam P Vogel; Gary Rance; Sarah E M Stephenson; Joseph P Sarsero; Creina Stockley; Chung-Yung J Lee; Andrew Churchyard; Marguerite V Evans-Galea; Monique M Ryan; Paul J Lockhart; Louise A Corben; Martin B Delatycki
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

8.  Auditory pathway changes mirror overall disease progress in individuals with Friedreich ataxia.

Authors:  Gary Rance; Louise A Corben; Martin B Delatycki
Journal:  J Neurol       Date:  2012-09-30       Impact factor: 4.849

9.  Auditory function in Pelizaeus-Merzbacher disease.

Authors:  Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

Review 10.  Evaluating the progression of Friedreich ataxia and its treatment.

Authors:  Martin B Delatycki
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.